Initially, only patients with four weight-related health problems and a BMI of 40 or more (adjusted for ethnicity) will be eligible to access tirzepatide (Mounjaro) through primary care settings in England 41
At ThinWorks, we understand that health is not one-size-fits-all
The study underscores the importance of long-term commitment
Finan B, Yang B, Ottaway N et al (2012) Targeted estrogen delivery reverses the metabolic syndrome
The general peptide dosage chart provides broader context for how tirzepatide dosing compares to other compounds
Sources Consulted Secondary data for the market study was gathered from multiple credible sources, including: Government databases, regulatory bodies, and public institutions International organizations (WHO, OECD, IMF, World Bank, etc.) Commercial and paid databases Industry associations, trade publications, and technical journals Company annual reports, investor presentations, press releases, and SEC filings Academic research papers, patents, and scientific literature Previous market research publications and syndicated reports These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights
